Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways

doi:10.4254/wjh.v15.i11.1237

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2203)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

1148

Figures (1-5)

196

Tables (1-2)

173

Sum=1622

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

133

Download

358

Sum=491

Nov 27, 2023 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Hepatol. Nov 27, 2023; 15(11): 1237-1249
Published online Nov 27, 2023. doi: 10.4254/wjh.v15.i11.1237

Table 1 Demographic and clinical characteristics of all study participants, distributed by fibrosis grade (Metavir score)

Variables	Healthy control	Fibrosis grade (Metavir)¹
Variables	Healthy control	F1	F2	F3	F4
Age (yr)	44 ± 12.2	50 ± 10.78	49 ± 8.6	55 ± 8.8	54 ± 11.22
Sex
Male	24 (65.0)	8 (61.5)	7 (58.3)	5 (100)	9 (60.0)
Female	26 (52.0)	5 (38.5)	5 (41.7)	0	6 (40.0)
BMI (kg/m²)	22.9 ± 2.98	28.3 ± 8.89	26.5 ± 6.26	26.9 ± 3.60	27.4 ± 7.14
HCV genotype
1²	-	10 (77.0)	8 (66.7)	3 (50.0)	12 (80.0)
Not 1³	-	3 (23.0)	4 (33.3)	3 (50.0)	3 (20.0)

¹Metavir score to assess the fibrosis grade by histopathological examination of a liver biopsy.

²HCV 1: Hepatitis C Virus genotype 1.

³HCV not 1: Hepatitis C Virus other genotypes.

BMI: Body mass index; HCV: Hepatitis C virus.

Citation: Ferrasi AC, Lima SVG, Galvani AF, Delafiori J, Dias-Audibert FL, Catharino RR, Silva GF, Praxedes RR, Santos DB, Almeida DTM, Lima EO. Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways. World J Hepatol 2023; 15(11): 1237-1249
URL: https://www.wjgnet.com/1948-5182/full/v15/i11/1237.htm
DOI: https://dx.doi.org/10.4254/wjh.v15.i11.1237